Pan-cancer analysis identified CCDC58 overexpression in LUAD (Figure 1A), which was validated in TCGA datasets showing significantly higher CCDC58 levels in LUAD versus NAT (Figure 1B). This evidence concerns the gene MIX23 and cancer.